COMMUNIQUÉS West-GlobeNewswire

-
Emerald Health Therapeutics Reports 2nd Quarter 2018 Financial Results and Provides Corporate Update
30/08/2018 -
CTD Holdings Discusses its Phase I Clinical Trial for Intravenous Use of Trappsol® Cyclo™ in Niemann-Pick Disease Type C
30/08/2018 -
Ogilvy CommonHealth Worldwide’s payer community flourishes with three executive level promotions
30/08/2018 -
Surface Oncology to Present at the Baird 2018 Global Healthcare Conference
30/08/2018 -
Agility Health Reports Second Quarter 2018 Financial Results
30/08/2018 -
On “Grindeks” Results in the First Six Months of 2018
30/08/2018 -
Two Global Cannabis Leaders Partnering to Bring Science-Based Innovations to the International Cannabis Marketplace -- CFN Media
30/08/2018 -
Trillium to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
30/08/2018 -
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
30/08/2018 -
Mateon Therapeutics to Present at the Rodman & Renshaw Investor Conference on September 6, 2018
30/08/2018 -
Digital Health Transformation Leader Daniel Garrett, Former PwC Partner, Joins Welldoc® Board of Directors
30/08/2018 -
Trends to Watch as Cannabis Moves into the Health & Wellness Market -- CFN Media
30/08/2018 -
Predictive Technology Group to Present at H.C. Wainwright 20th Annual Global Investment Conference
30/08/2018 -
Captor Capital: A Hidden Gem Growing Quickly in the Attractive Cannabis Sector -- CFN Media
30/08/2018 -
ContraVir Pharmaceuticals Announces Participation at the 20th Annual Global Investment Conference in New York City September 4-6, 2018
30/08/2018 -
CV Sciences, Inc. provides corporate update to shareholders
30/08/2018 -
ICC Labs Files Financial Results for the Second Quarter Ended June 30 and Completes the Construction of Its 124,000 sq. ft. Greenhouse in Colombia to Produce Psychoactive Medicinal Cannabis
30/08/2018 -
Cesca Therapeutics to Present at the H.C. Wainwright 20th Annual Global Investment Conference
30/08/2018 -
Ultragenyx to Present at Upcoming Investor Conferences
30/08/2018
Pages